EUVIMEDEUVIMED entdecken
Crossref

Short-term prognostic factors of rituximab combined with glucocorticoids in the treatment of pemphigus: A multicenter retrospective study

Zhili Wu, Jiefeng Jiang, Shuomin Chen, Yiqian Peng, Xueting Yang, Yiu Nam, Cong Zhang, Feng Guo, Gang Hu, Guiying Zhang, Jinbo Chen, Ruzeng Xue

Journal of the American Academy of Dermatology · 2026-09

DOI: 10.1016/j.jaad.2026.09.023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-09. Verfasst von Zhili Wu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Dermatology Hospital, Southern Medical University, Guangzhou, China. Die Arbeit nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Rituximab (RTX), combined with glucocorticoids, is a first-line treatment for pemphigus, yet short-term prognostic outcomes and their predictors remain underexplored in Chinese populations. OBJECTIVE: To evaluate the 52-week outcomes of RTX combined with glucocorticoids in a real-world Chinese cohort and identify independent predictors of complete remission on minimal therapy (CR mini) and relapse. METHODS: This multicenter retrospective study included 276 pemphigus patients who received initial RTX combined with glucocorticoids. Univariate and multivariate logistic regression analyses were performed to identify predictors of CR mini and relapse. RESULTS: Over 52 weeks, 134 (48.6%) patients achieved CR mini, and 35 (12.7%) relapsed. Independent predictors for CR mini were 3 RTX infusions, higher baseline immunoglobulin M level and absence of baseline herpes simplex virus infection. For relapse, independent predictors were higher body weight, prior immunosuppressant use, and prior cyclophosphamide use. Adverse events occurred in 23.2% of patients, primarily infections, with no significant differences across prognostic subgroups. LIMITATIONS: Retrospective design and absence of dynamic biomarkers. CONCLUSION: This study identifies readily obtainable baseline predictors for CR mini and relapse in RTX-treated pemphigus, facilitating early risk stratification and individualized treatment strategies to optimize long-term outcomes.

Schlagwörter

Stichwörter der Autor:innen

complete remissionpemphigusrelapserituximabsafety

Autor:innen und Institutionen

  • Department of Dermatology, Dermatology Hospital, Southern Medical University, Guangzhou, China.
  • Department of Dermatology, Dermatology Hospital, Southern Medical University, Guangzhou, China; The First School of Clinical Medicine, Southern Medical University, Guangzhou, China.
  • Department of Dermatology, Traditional Chinese and Western Medicine Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Department of Dermatology, Wuhan No.1 Hospital,…
  • Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Department of Dermatology, Wuhan No.1 Hospital, Wuhan, China.
  • Department of Dermatology, Dermatology Hospital, Southern Medical University, Guangzhou, China. Electronic address: xueruzeng@163.com.

Zitieren

APA

Wu, Z., Jiang, J., Chen, S., Peng, Y., Yang, X., Nam, Y., Zhang, C., Guo, F., Hu, G., Zhang, G., Chen, J., & Xue, R. (2026). Short-term prognostic factors of rituximab combined with glucocorticoids in the treatment of pemphigus: A multicenter retrospective study. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.09.023

Vancouver

Wu Z, Jiang J, Chen S, Peng Y, Yang X, Nam Y, et al. Short-term prognostic factors of rituximab combined with glucocorticoids in the treatment of pemphigus: A multicenter retrospective study. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2026.09.023

BibTeX
@article{Wu2026,
  author = {Wu, Zhili and Jiang, Jiefeng and Chen, Shuomin and Peng, Yiqian and Yang, Xueting and Nam, Yiu and Zhang, Cong and Guo, Feng and Hu, Gang and Zhang, Guiying and Chen, Jinbo and Xue, Ruzeng},
  title = {Short-term prognostic factors of rituximab combined with glucocorticoids in the treatment of pemphigus: A multicenter retrospective study},
  journal = {Journal of the American Academy of Dermatology},
  year = {2026},
  doi = {10.1016/j.jaad.2026.09.023}
}
Kostenlos starten →